Psychiatry Investig.
2009 Jun;6(2):55-58.
Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective
- Affiliations
-
- 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC, USA. pae@catholic.ac.kr
- 2Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, Korea.
Abstract
- Pregabalin is a newly developed synthetic gamma-aminobutyric acid (GABA) that is approved for the treatment of fibromyalgia and several neuropathy. It has been proven to show analgesic, anxiolytic, anticonvulsant and sleep enhancement effects, which could be applicable in the treatment of a variety of psychiatric disorders. There have been consistent reports that unexplained somatic symptoms (i.e., pain) may be a part of psychiatric disorders such as major depressive disorder (MDD) and anxiety disorders. Previous researches have also suggested the possible therapeutic potential of anticonvulsants as augmentation therapy or monotherapy in the treatment of mood disorders and anxiety disorders. Hence this short perspective tries to prompt and facilitate a shifting of researchers' attention to potential neuropsychotropic drug role of pregabalin to treat a wide range of neuropsychiatric disorders.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case Report of Syndrome of Inappropriate Antidiuretic Hormone Induced by Pregabalin
- Negative myoclonus associated with pregabalin
- Pharmacotherapy of Generalized Anxiety Disorder and Pregabalin
- Effects of pregabalin and gabapentin on postoperative pain and opioid consumption after laparoscopic cholecystectomy
- Antiallodynic Effect of Pregabalin in Rat Models of Sympathetically Maintained and Sympathetic Independent Neuropathic Pain
